75 related articles for article (PubMed ID: 21771527)
1. Preparation and in vitro characterisation of Ehrlichia ruminantium plasmid DNA and proteins encapsulated into and DNA adsorbed onto biodegradable microparticles.
Tshikhudo N; Pretorius A; Putterill J; van Kleef M
Ticks Tick Borne Dis; 2010 Dec; 1(4):186-93. PubMed ID: 21771527
[TBL] [Abstract][Full Text] [Related]
2. Protection against heartwater by DNA immunisation with four Ehrlichia ruminantium open reading frames.
Pretorius A; Collins NE; Steyn HC; van Strijp F; van Kleef M; Allsopp BA
Vaccine; 2007 Mar; 25(12):2316-24. PubMed ID: 17224211
[TBL] [Abstract][Full Text] [Related]
3. Development of improved attenuated and nucleic acid vaccines for heartwater.
Collins NE; Pretorius A; van Kleef M; Brayton KA; Allsopp MT; Zweygarth E; Allsopp BA
Dev Biol (Basel); 2003; 114():121-36. PubMed ID: 14677683
[TBL] [Abstract][Full Text] [Related]
4. A heterologous prime/boost immunisation strategy protects against virulent E. ruminantium Welgevonden needle challenge but not against tick challenge.
Pretorius A; van Kleef M; Collins NE; Tshikudo N; Louw E; Faber FE; van Strijp MF; Allsopp BA
Vaccine; 2008 Aug; 26(34):4363-71. PubMed ID: 18602727
[TBL] [Abstract][Full Text] [Related]
5. Studies of a polymorphic Ehrlichia ruminantium gene for use as a component of a recombinant vaccine against heartwater.
Pretorius A; Liebenberg J; Louw E; Collins NE; Allsopp BA
Vaccine; 2010 Apr; 28(20):3531-9. PubMed ID: 20338214
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of different buffers on plasmid DNA encapsulation into PLGA microparticles.
Tse MT; Blatchford C; Oya Alpar H
Int J Pharm; 2009 Mar; 370(1-2):33-40. PubMed ID: 19059325
[TBL] [Abstract][Full Text] [Related]
7. Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination.
Oster CG; Kim N; Grode L; Barbu-Tudoran L; Schaper AK; Kaufmann SH; Kissel T
J Control Release; 2005 May; 104(2):359-77. PubMed ID: 15907586
[TBL] [Abstract][Full Text] [Related]
8. Immunisation of sheep against heartwater in The Gambia using inactivated and attenuated Ehrlichia ruminantium vaccines.
Faburay B; Geysen D; Ceesay A; Marcelino I; Alves PM; Taoufik A; Postigo M; Bell-Sakyi L; Jongejan F
Vaccine; 2007 Nov; 25(46):7939-47. PubMed ID: 17920167
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles.
Pai Kasturi S; Qin H; Thomson KS; El-Bereir S; Cha SC; Neelapu S; Kwak LW; Roy K
J Control Release; 2006 Jul; 113(3):261-70. PubMed ID: 16793161
[TBL] [Abstract][Full Text] [Related]
10. Preparation and immunological effectiveness of a Swine influenza DNA vaccine encapsulated in PLGA microspheres.
Zhao K; Li GX; Jin YY; Wei HX; Sun QS; Huang TT; Wang YF; Tong GZ
J Microencapsul; 2010; 27(2):178-86. PubMed ID: 20121488
[TBL] [Abstract][Full Text] [Related]
11. Issues in long-term protein delivery using biodegradable microparticles.
Ye M; Kim S; Park K
J Control Release; 2010 Sep; 146(2):241-60. PubMed ID: 20493221
[TBL] [Abstract][Full Text] [Related]
12. Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles.
He X; Jiang L; Wang F; Xiao Z; Li J; Liu LS; Li D; Ren D; Jin X; Li K; He Y; Shi K; Guo Y; Zhang Y; Sun S
J Control Release; 2005 Oct; 107(2):357-72. PubMed ID: 16099068
[TBL] [Abstract][Full Text] [Related]
13. Process considerations related to the microencapsulation of plasmid DNA via ultrasonic atomization.
Ho J; Wang H; Forde GM
Biotechnol Bioeng; 2008 Sep; 101(1):172-81. PubMed ID: 18646229
[TBL] [Abstract][Full Text] [Related]
14. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.
Gargouri M; Sapin A; Arıca-Yegin B; Merlin JL; Becuwe P; Maincent P
Int J Pharm; 2011 Jan; 403(1-2):276-84. PubMed ID: 21044878
[TBL] [Abstract][Full Text] [Related]
15. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
[TBL] [Abstract][Full Text] [Related]
16. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
Díez S; Tros de Ilarduya C
Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172
[TBL] [Abstract][Full Text] [Related]
17. Development of improved vaccines for heartwater.
Mahan SM; Barbet AF; Burridge MJ
Dev Biol (Basel); 2003; 114():137-45. PubMed ID: 14677684
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of five low molecular weight proteins of Ehrlichia ruminantium as potential vaccine components.
Sebatjane SI; Pretorius A; Liebenberg J; Steyn H; Van Kleef M
Vet Immunol Immunopathol; 2010 Oct; 137(3-4):217-25. PubMed ID: 20566221
[TBL] [Abstract][Full Text] [Related]
19. Cationic microparticles are a potent delivery system for a HCV DNA vaccine.
O'Hagan DT; Singh M; Dong C; Ugozzoli M; Berger K; Glazer E; Selby M; Wininger M; Ng P; Crawford K; Paliard X; Coates S; Houghton M
Vaccine; 2004 Dec; 23(5):672-80. PubMed ID: 15542189
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of PLGA microparticles as carrier for the pulmonary delivery of rhIL-2 : I. Effects of some formulation parameters on microparticle characteristics.
Devrim B; Bozkir A; Canefe K
J Microencapsul; 2011; 28(6):582-94. PubMed ID: 21827360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
